Education
About Us
Working with TipRanks
Follow Us
OKYO Pharma Limited Sponsored ADR (OKYO)
:OKYO
Total Valuation
OKYO Pharma Limited Sponsored ADR has a market cap or net worth of $81.24M. The enterprise value is $44.19M.
Market Cap$81.24M
Enterprise Value$44.19M
Share Statistics
OKYO Pharma Limited Sponsored ADR has 37,610,676 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding37,610,676
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
OKYO Pharma Limited Sponsored ADR’s return on equity (ROE) is 0.85 and return on invested capital (ROIC) is 76.49%.
Return on Equity (ROE)0.85
Return on Assets (ROA)-1.28
Return on Invested Capital (ROIC)76.49%
Return on Capital Employed (ROCE)1.30
Revenue Per Employee0.00
Profits Per Employee-2.66M
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of OKYO Pharma Limited Sponsored ADR is ―. OKYO Pharma Limited Sponsored ADR’s PEG ratio is -0.00054.
PE Ratio―
PS Ratio0.00
PB Ratio-9.04
Price to Fair Value-9.04
Price to FCF-27.67
Price to Operating Cash Flow-56.55
PEG Ratio-0.00054
Income Statement
In the last 12 months, OKYO Pharma Limited Sponsored ADR had revenue of 0.00 and earned -4.71M in profits. Earnings per share was -0.12.
Revenue0.00
Gross Profit-2.56K
Operating Income-7.19M
Pretax Income-7.97M
Net Income-4.71M
EBITDA-7.08M
Earnings Per Share (EPS)-0.12
Cash Flow
In the last 12 months, operating cash flow was -1.81M and capital expenditures -1.20K, giving a free cash flow of -1.81M billion.
Operating Cash Flow-1.81M
Free Cash Flow-1.81M
Free Cash Flow per Share-0.05
Dividends & Yields
OKYO Pharma Limited Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.27
52-Week Price Change94.34%
50-Day Moving Average2.22
200-Day Moving Average2.07
Relative Strength Index (RSI)48.60
Average Volume (3m)150.40K
Important Dates
OKYO Pharma Limited Sponsored ADR upcoming earnings date is Aug 5, 2025, TBA (Confirmed).
Last Earnings DateNov 29, 2024
Next Earnings DateAug 5, 2025
Ex-Dividend Date―
Financial Position
OKYO Pharma Limited Sponsored ADR as a current ratio of 0.40, with Debt / Equity ratio of 0.00%
Current Ratio0.40
Quick Ratio0.40
Debt to Market Cap0.00
Net Debt to EBITDA0.22
Interest Coverage Ratio-8.14
Taxes
In the past 12 months, OKYO Pharma Limited Sponsored ADR has paid -3.26M in taxes.
Income Tax-3.26M
Effective Tax Rate0.41
Enterprise Valuation
OKYO Pharma Limited Sponsored ADR EV to EBITDA ratio is -6.86, with an EV/FCF ratio of -26.81.
EV to Sales0.00
EV to EBITDA-6.86
EV to Free Cash Flow-26.81
EV to Operating Cash Flow-26.83
Balance Sheet
OKYO Pharma Limited Sponsored ADR has $1.56M in cash and marketable securities with $0.00 in debt, giving a net cash position of $1.56M billion.
Cash & Marketable Securities$1.56M
Total Debt$0.00
Net Cash$1.56M
Net Cash Per Share$0.04
Tangible Book Value Per Share-$0.14
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for OKYO Pharma Limited Sponsored ADR is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside146.91% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―